Tai chi or cognitive behavioural therapy for treating insomnia in middle aged and older adults: randomised non-inferiority trial

作者
Parco M Siu,Danny J Yu,Angus P. Yu,Francesco Recchia,Shirley X. Li,Rachel NY Chan,Daniel Y Fong,Derwin Kc Chan,Stanley Sc Hui,Ka-Fai Chung,Jean Woo,Chenchen Wang,Michael R. Irwin
出处
期刊: 卷期号:391: e084320-e084320
标识
DOI:10.1136/bmj-2025-084320
摘要

Abstract Objective To assess whether tai chi is non-inferior to cognitive behavioural therapy for insomnia (CBT-I), the first line treatment, for managing chronic insomnia in middle aged and older adults. Design Randomised, assessor masked, non-inferiority trial. Setting A single research site in Hong Kong with participants recruited from the local community between 18 May 2020 and 14 July 2022. Participants Chinese participants aged ≥50 years with chronic insomnia diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders , fifth edition. Interventions Tai chi and CBT-I interventions were delivered in group format over three months, consisting of one hour sessions twice a week for a total of 24 sessions. Main outcome measures The primary outcome was the change in perceived insomnia severity measured by the Insomnia Severity Index after the intervention (month 3) and at 12 month follow-up (month 15). To assess whether tai chi is non-inferior to CBT-I, a threshold of four points was used as the margin of non-inferiority. Results 200 participants were randomised (1:1) to receive tai chi (n=100) or CBT-I (n=100). The per protocol principle was adopted. At month 3, the tai chi group showed a reduction of 6.67 (95% confidence interval 5.61 to 7.73) in Insomnia Severity Index scores, while the CBT-I group had a reduction of 11.19 (10.06 to 12.32), resulting in a between group difference of 4.52 (−∞ to 5.81). Tai chi was deemed inferior to CBT-I at month 3 because the upper confidence limit exceeded the non-inferiority margin. At month 15, the reductions for tai chi and CBT-I were 9.51 (8.47 to 10.54) and 10.18 (8.97 to 11.40), respectively, with a between group difference of 0.68 (−∞ to 2.00). At this point, tai chi was considered non-inferior to CBT-I because the upper confidence limit fell within the non-inferiority margin. Results from the intention-to-treat analysis were consistent with the per protocol findings. No adverse events occurred during the intervention period. Conclusion Tai chi was inferior to CBT-I at month 3 but non-inferior at month 15. This finding supports the use of tai chi as an alternative approach for the long term management of chronic insomnia in middle aged and older adults. Trial registration ClinicalTrials.gov NCT04384822
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
晓晓完成签到,获得积分20
刚刚
爱笑的醉卉完成签到,获得积分10
刚刚
1秒前
1秒前
2秒前
2秒前
脑洞疼应助友好大凄采纳,获得10
2秒前
半生晴天完成签到,获得积分10
2秒前
guobiao发布了新的文献求助10
5秒前
打打应助Kumiko采纳,获得10
5秒前
6秒前
ZYT完成签到,获得积分20
6秒前
ABCDEFG完成签到,获得积分10
7秒前
8秒前
摇摆小狗发布了新的文献求助10
8秒前
linshunan发布了新的文献求助10
9秒前
ZYT发布了新的文献求助10
9秒前
10秒前
ll完成签到,获得积分20
11秒前
踏实的绿柏完成签到,获得积分10
11秒前
11秒前
小猪发布了新的文献求助10
12秒前
XLL发布了新的文献求助10
12秒前
健忘香彤完成签到,获得积分10
12秒前
13秒前
13秒前
15秒前
15秒前
欣慰的海发布了新的文献求助10
15秒前
希望天下0贩的0应助pcg采纳,获得10
16秒前
dopamine完成签到,获得积分20
16秒前
哇哈哈哈发布了新的文献求助10
17秒前
17秒前
18秒前
18秒前
Kumiko发布了新的文献求助10
18秒前
明天见完成签到,获得积分10
18秒前
科目三应助brand采纳,获得10
18秒前
李多多完成签到,获得积分10
19秒前
tmj完成签到,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
An Introduction to Foreign Language Learning and Teaching 750
China Pluperfect I: Epistemology of Past and Outside in Chinese Art 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 500
What is the Future of Psychotherapy in Digital Age? Technology, AI Bots, and Psychotherapy after Covid 444
煤炭地下气化渗流燃烧方法的研究 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7632041
求助须知:如何正确求助?哪些是违规求助? 9206467
关于积分的说明 19744653
捐赠科研通 7201360
什么是DOI,文献DOI怎么找? 3274739
关于科研通互助平台的介绍 2436632
邀请新用户注册赠送积分活动 2271402